Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)
China flag China · Delayed Price · Currency is CNY
7.62
+0.04 (0.53%)
Jul 17, 2025, 2:45 PM CST

SHE:002693 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Operating Revenue
163.41169.49231.06250.33303.56251.48
Upgrade
Other Revenue
4.714.714.8724.4216.7417.96
Upgrade
168.12174.21235.93274.75320.29269.44
Upgrade
Revenue Growth (YoY)
-14.75%-26.16%-14.13%-14.22%18.87%-22.27%
Upgrade
Cost of Revenue
85.7984.3882.4194.6587.6865.74
Upgrade
Gross Profit
82.3389.83153.52180.1232.61203.7
Upgrade
Selling, General & Admin
137.14143.19175.23202.13264.62244.34
Upgrade
Research & Development
11.3412.897.9614.5910.6212.18
Upgrade
Other Operating Expenses
4.525.356.027.717.037.18
Upgrade
Operating Expenses
153.08161.6190.35224.34282.23264.06
Upgrade
Operating Income
-70.76-71.77-36.83-44.24-49.62-60.35
Upgrade
Interest Expense
-9.67-9.23-9.58-11.19-9.03-10.01
Upgrade
Interest & Investment Income
0.590.732.794.754.172.94
Upgrade
Currency Exchange Gain (Loss)
0.360.360.120.01-0.1-0.29
Upgrade
Other Non Operating Income (Expenses)
0.04-0.04-0.18-0.05-0.81-4.63
Upgrade
EBT Excluding Unusual Items
-79.45-79.96-43.69-50.71-55.39-72.34
Upgrade
Gain (Loss) on Sale of Investments
-9.91-10.09-39.85-0.06--
Upgrade
Gain (Loss) on Sale of Assets
-0.06-0.070.7929.913.74-1.21
Upgrade
Asset Writedown
-18.96-18.96--2.1--9.95
Upgrade
Other Unusual Items
2.92.99.7814.091.294.72
Upgrade
Pretax Income
-105.48-106.17-72.97-8.88-40.36-78.78
Upgrade
Income Tax Expense
0.10.1-0.99-0.380.451.17
Upgrade
Earnings From Continuing Operations
-105.58-106.27-71.98-8.5-40.81-79.95
Upgrade
Minority Interest in Earnings
25.9827.9621.2317.5120.4826.62
Upgrade
Net Income
-79.6-78.3-50.749.01-20.33-53.33
Upgrade
Net Income to Common
-79.6-78.3-50.749.01-20.33-53.33
Upgrade
Shares Outstanding (Basic)
412412423451407410
Upgrade
Shares Outstanding (Diluted)
412412423451407410
Upgrade
Shares Change (YoY)
-2.77%-2.53%-6.16%10.85%-0.91%-0.17%
Upgrade
EPS (Basic)
-0.19-0.19-0.120.02-0.05-0.13
Upgrade
EPS (Diluted)
-0.19-0.19-0.120.02-0.05-0.13
Upgrade
Free Cash Flow
-47-65.73-37.56-7.77-8.09-62.07
Upgrade
Free Cash Flow Per Share
-0.11-0.16-0.09-0.02-0.02-0.15
Upgrade
Gross Margin
48.97%51.56%65.07%65.55%72.62%75.60%
Upgrade
Operating Margin
-42.09%-41.20%-15.61%-16.10%-15.49%-22.40%
Upgrade
Profit Margin
-47.35%-44.95%-21.51%3.28%-6.35%-19.79%
Upgrade
Free Cash Flow Margin
-27.96%-37.73%-15.92%-2.83%-2.52%-23.04%
Upgrade
EBITDA
-18.49-19.4315.8413.34.71-3.26
Upgrade
EBITDA Margin
-11.00%-11.15%6.71%4.84%1.47%-1.21%
Upgrade
D&A For EBITDA
52.2652.3452.6757.5454.3357.09
Upgrade
EBIT
-70.76-71.77-36.83-44.24-49.62-60.35
Upgrade
EBIT Margin
-42.09%-41.20%-15.61%-16.10%-15.49%-22.40%
Upgrade
Revenue as Reported
168.12174.21235.93274.75320.29269.44
Upgrade
Advertising Expenses
-1.570.07---
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.